Abstract
Plant derived agents may exert a new approach to the treatment of leukaemia. The present study was an evaluation of proliferation, cytotoxicity and differentiation of harmine and harmaline on HL60 cells, alone or in combination with ATRA and G-CSF. Counting of cells, viability, MTT assay, morphology, NBT reduction and flow cytometry analysis were performed using CD11b and CD 14 monoclonal antibodies. The data showed that harmine and harmaline reduced proliferation in dose and time dependent manner. Optimal antiproliferative concentration of these agents was chosen. However, both agents in higher doses were cytotoxic. Combination of ATRA, G-CSF and each agent alone, particularly harmaline in optimal dose, resulted in partially additive decrease in cell proliferation. Cells treated with both harmaline and ATRA demonstrated some morphological changes and NBT positivity, but the extent of changes observed following treatment with harmaline was less than ATRA. Flow cytometric analysis showed that ATRA induced a neutrophilic differentiation, while harmaline led to a predominantly monocytic differentiation. Combination of harmine and harmaline with ATRA and G-CSF did not change the extent of differentiation, and the cells differentiated into the neutrophilic lineage. This shows that the direction of differentiation is dominantly determined by ATRA. These preliminary data implies a new approach in treatment of leukemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Advani, S. H., Nair, R., Bapna, A., Gladstone, B., KActam, P., Saikia, T. K., Parekh, P. M., Gopal, R., and Nair, C. N., Acute promyelocytic leukaemia, All trans retionic acid with chemotherapy is superior to ATRA alone.Am. J. Hematol., 60, 87–93(1999).
Al-Allaf, T. A., Khuzaie, R. F., Rashan, L. J., and Halaseh, W. R., Cytotoxic activity of a series of tumor cell lines with various tumor ligands.Boll. Chim. Farm., 138, 267–271 (1999).
Boeira, J. M., dasilva, J., Erdtmann, B., and Henriques, J., Genotoxic effect of alkaloid Harmane and Harmine asses by commet assay in mammalian cell in vitro.Pharmacol. Toxicol., 89, 287–294 (2001).
Brackman, D., Lund-Johansen, R, and Aarskog, D., Expression of cell surface antigens during the differentiation of HL60 cells induced by 1,25-Dihydroxyvitamin D3, retinoic acid and DMSO.Leukemia Res., 19, 57–64 (1995).
Cao, R., Chen, H., Peng, W, Ma, Y, Hou, X., Guan, H., Liu, X., and Xu, A., Design,synthesis and in vitro and in vivo anti tumor activities of novel beta-carboline derivatives.Eur. J. Med. Chem., 40, 991–1001 (2005).
Chen, Q., Choa, R., Chen, H., Hou, X., Yan, H., Zhou, S., Peng, W., and Xu, A., Antitumor and neurotoxic effects of novel Harmine derivatives and structure-activity relationship analysis.Int. J. Cancer., 114, 675–682 (2005).
Dover, D., New advances in the treatment of acute promyelocytic leukaemia.Int. J. Hematol., Supp II, 179–187 (2002).
Penoux, P. and Degos, L, Differentiation therapy for acute promyelocytic leukaemia.N. Engl. J. Med, 337,1076–1078 (1997).
Hozumi, M., Pundamentals of chemo-differentiation therapy of myeloid leukaemia.Anti Cancer. Res., 14,1175–1192 (1994).
Ishida, J., Wang, H. K., Bastow, K. F., Hu, C. Q., and Lee, K. H, Anti tumor agents (201) cytotoxicity of Harmine and B- carboline analogs.Bioorg. Med. Chem. Lett., 9, 3319–3324 (1999).
Jahaniani, R, Ebrahimi, S. A., Rahbar-Roshandel, N., and Mahmoudian, M., Xanthomicrol is the main cytotoxic component of Dracocephalum hotschyii and a potential anti-cancer agent.Phytochemistry, 66,1581–1592 (2005).
James, S. Y, Williams, M. A., Newland, A. C, and Closton, K. W., Leukaemia cell differentiation. Cellular and molecular interaction of retinoids and Vitamin D.Gen Pharmacol., 32,143–154(1999).
Miller, W. H. Jr., Molecular targets of arsenic trioxide in malignant cells.Oncologist, 7,1–13(2002).
Mosmann, T., Rapid colorometric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays.J. Immunol Methods, 65, 55–63 (1983).
Muto, A., Kizaki, M., Kawamura, C, Matsushita, H., Funchochi, Y, Umezewa, A., YamActa, T., Hata, J., Huzomi, N., Yamato, K., Ito, M., Ueyama, Y, and Ikeda, Y, A novel differentiation- inducing therapy for APL with a combination of arsenic trioxide and GM-CSF.Leukaemia,15,1176–1184 (2001).
Niu, C, Yan, H, Yu, T., Sun, H. P., Liu, J. X., Li, X. S., Wu, W., Zhung, F. Q., and Chen, Y, Studies on treatment of acute promyelocytic leukaemia with arsenic trioxide.Blood, 94, 3315–3324(1999).
Olsson, I., Bergh, G, Ehinger, M., and Gullberg, U., Cell differentia-tion in AML.Eur. J. Hematol., 57,1–16 (1996).
Peck, R. and Bollag, W., Potentiation of retinoid-induced differentiation of HL60 and U937 cell lines by cytokins.Eur. J. Cancer., 27, 53–57(1991).
Lamchouri, F., Settaf, A., Cherrah, Y, Hasser, M., Zemzami, M., Arif, N., Nadori, E. B., Zaid, A., and Lyoussi, B., In vitro cell toxcicity of peganum harmala alkaloids on cancerous cell lines.Fitoterapia, 71, 50–54 (2000).
Slack, J. L. and Rusinlak, M. E., Current issues in manegement of APL.Ann. Hematol., 79, 227–238 (2000).
Sobhani, A. M., Ebrahimi, S. A., and Mahmoodiani, M., In vitro evaluation of human DNA topo isomerase I inhibition by peganum Harmala and its beta Carolin alkaloids.J. Pharm. Sci., 5, 19–23(2002).
Tallman, M. S., Nabhan, C, Feusner, J. H, and Rowe, J. M., Acute promyelocytic leukaemia. Evolving thérapie strategies.Blood, 99, 759–767 (2002).
Terpstra, W. and Lowenberg, B., Applications of myeloid growth factors in the treatment of acute myeloid leukaemia.Leukaemia, 11, 315–327 (1997).
Wang, Z. G, Rivi, R., Delva, L, Kongi, A., Sheinberg, D. A., Gambacorti-Passerini, C, Gabrilove, J. L., Warrell, R. P., and Pandolfi, P. P., Arsenic trioxide induce cell death in myeloid leukaemia. Stood, 92,1497–1504 (1998).
Waxman, S., Differentiation therapy in AML (non APL).Leukaemia, 14,491–496(2000).
Zaker, F, Darley, R. L., AI Sabah, A., and Burnet, A. K., Oncogenic RAS gene impair erythroid differentiation of erythroleukaemia cells.Leukaemia Res., 21, 635–640 (1997).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zaker, F., Oody, A. & Arjmand, A. A study on the antitumoral and differentiation effects of peganum harmala derivatives in combination with atra on leukaemic cells. Arch Pharm Res 30, 844–849 (2007). https://doi.org/10.1007/BF02978835
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02978835